Bio-Implants Comprehensive Study by Type (Cardiovascular Implants, Spinal implants, Orthopedic Implants, Dental Implants, Ophthalmic Implants, Others), End Users (Hospitals, Clinics, Ambulatory Surgical Centers, Others), Material (Ceramics, Polymers, Alloys, Biomaterials Metals, Others) Players and Region - Global Market Outlook to 2030

Bio-Implants Market by XX Submarkets | Forecast Years 2024-2030 | CAGR: 6.6%  

  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Bio-Implants Market Scope
Bioimplants refers to materials of human or animal origin that are offered after conservation or preparation for tissue replacement. They are used in the different fields of ENT with very good success. Bio-implants are artificial medical devices used to replace the missing biological system and the damaged biological system, as well as to support or enhance the existing biological structure. Implants can be of many types, such as load-bearing implants used in orthopedic applications, dental implants used in restoring the functionality and appearance of natural teeth, and implants used in the cardiovascular system. The materials used in the implants should be biocompatible, corrosion-resistant, and wear-resistant.

AttributesDetails
Study Period2018-2030
Base Year2023
UnitValue (USD Million)
Key Companies ProfiledAAP Implantate (Germany), Abbott Laboratories (United States), Bausch And Lomb Incorporated (Canada), Biomet (United States), Biotronik Se & Co.Kg (Germany), Boston Scientific Corporation (United States), Cook Group (United States), C.R. Bard (United States), Edwards Lifesciences Corporation (Unites States), Endo Health Solutions (Dublin) and Johnson & Johnson (Unites States)
CAGR6.6%


The Bio-implant market is vendor in the market to understood the competitive revalry we are the comparing the expense resource product portfolio. Research Analyst at AMA estimates that United States Players will contribute to the maximum growth of Global Bio-Implants market throughout the predicted period.

AAP Implantate (Germany), Abbott Laboratories (United States), Bausch And Lomb Incorporated (Canada), Biomet (United States), Biotronik Se & Co.Kg (Germany), Boston Scientific Corporation (United States), Cook Group (United States), C.R. Bard (United States), Edwards Lifesciences Corporation (Unites States), Endo Health Solutions (Dublin) and Johnson & Johnson (Unites States) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research are Mimedx Group (United States), Orthofix International (United States), Smith & Nephew (United Kingdom), Sorin (South korea), St. Jude Medical (United States) and Integra Lifesciences Holdings Corporation (Unites States).

About Approach
The research aims to propose a patent-based approach in searching for potential technology partners as a supporting tool for enabling open innovation. The study also proposes a systematic searching process of technology partners as a preliminary step to select the emerging and key players that are involved in implementing market estimations. While patent analysis is employed to overcome the aforementioned data- and process-related limitations, as expenses occurred in that technology allows us to estimate the market size by evolving segments as target market from the total available market.

Segmentation Overview
The study have segmented the market of Global Bio-Implants market by Type and Region with country level break-up.

On the basis of geography, the market of Bio-Implants has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). region held largest market share in the year 2023.

Market Leaders and their expansionary development strategies
In May 2023, Henry Schein announced agreement to acquire Brazil implant Manufacture S.I.N Implant System Henry Schein acquire S.I.N From Latin American private equity fund manager the southern cross Group subject to regulatory approval by Brazil Administrative council for Economic Defense
In December 2023, Johnson & Johnson MedTech acquired the privately held company Laminar, a US-based developer of a heart implant that reduces the chance of stroke.


Influencing Trend:
Growing awareness among patients about the benefits of bio-implants and Constant advancements in medical technology

Market Growth Drivers:
Increasing Aging Population, Rising Preference toward Minimally Invasive Surgeries and Increasing Demand of Bioimplants

Challenges:
High cost of biomaterial of challenges of bioimplant and metallic biomaterial is safety in laboratory.

Restraints:
High Cost of Bio-implants and Unfavorable Reimbursement Policies

Opportunities:
Focus on innovation in bioelectronic implants, which is increasingly facilitating novel strategies for clinical diagnosis and treatment.

Key Target Audience
Manufacturing, Providers, Suppliers, Distributer and Others

Report Objectives / Segmentation Covered

By Type
  • Cardiovascular Implants
  • Spinal implants
  • Orthopedic Implants
  • Dental Implants
  • Ophthalmic Implants
  • Others
By End Users
  • Hospitals
  • Clinics
  • Ambulatory Surgical Centers
  • Others

By Material
  • Ceramics
  • Polymers
  • Alloys
  • Biomaterials Metals
  • Others

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increasing Aging Population
      • 3.2.2. Rising Preference toward Minimally Invasive Surgeries
      • 3.2.3. Increasing Demand of Bioimplants
    • 3.3. Market Challenges
      • 3.3.1. High cost of biomaterial of challenges of bioimplant
      • 3.3.2. Metallic biomaterial is safety in laboratory.
    • 3.4. Market Trends
      • 3.4.1. Growing awareness among patients about the benefits of bio-implants
      • 3.4.2. Constant advancements in medical technology
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Bio-Implants, by Type, End Users, Material and Region (value, volume and price ) (2018-2023)
    • 5.1. Introduction
    • 5.2. Global Bio-Implants (Value)
      • 5.2.1. Global Bio-Implants by: Type (Value)
        • 5.2.1.1. Cardiovascular Implants
        • 5.2.1.2. Spinal implants
        • 5.2.1.3. Orthopedic Implants
        • 5.2.1.4. Dental Implants
        • 5.2.1.5. Ophthalmic Implants
        • 5.2.1.6. Others
      • 5.2.2. Global Bio-Implants by: End Users (Value)
        • 5.2.2.1. Hospitals
        • 5.2.2.2. Clinics
        • 5.2.2.3. Ambulatory Surgical Centers
        • 5.2.2.4. Others
      • 5.2.3. Global Bio-Implants by: Material (Value)
        • 5.2.3.1. Ceramics
        • 5.2.3.2. Polymers
        • 5.2.3.3. Alloys
        • 5.2.3.4. Biomaterials Metals
        • 5.2.3.5. Others
      • 5.2.4. Global Bio-Implants Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
    • 5.3. Global Bio-Implants (Volume)
      • 5.3.1. Global Bio-Implants by: Type (Volume)
        • 5.3.1.1. Cardiovascular Implants
        • 5.3.1.2. Spinal implants
        • 5.3.1.3. Orthopedic Implants
        • 5.3.1.4. Dental Implants
        • 5.3.1.5. Ophthalmic Implants
        • 5.3.1.6. Others
      • 5.3.2. Global Bio-Implants by: End Users (Volume)
        • 5.3.2.1. Hospitals
        • 5.3.2.2. Clinics
        • 5.3.2.3. Ambulatory Surgical Centers
        • 5.3.2.4. Others
      • 5.3.3. Global Bio-Implants by: Material (Volume)
        • 5.3.3.1. Ceramics
        • 5.3.3.2. Polymers
        • 5.3.3.3. Alloys
        • 5.3.3.4. Biomaterials Metals
        • 5.3.3.5. Others
      • 5.3.4. Global Bio-Implants Region
        • 5.3.4.1. South America
          • 5.3.4.1.1. Brazil
          • 5.3.4.1.2. Argentina
          • 5.3.4.1.3. Rest of South America
        • 5.3.4.2. Asia Pacific
          • 5.3.4.2.1. China
          • 5.3.4.2.2. Japan
          • 5.3.4.2.3. India
          • 5.3.4.2.4. South Korea
          • 5.3.4.2.5. Taiwan
          • 5.3.4.2.6. Australia
          • 5.3.4.2.7. Rest of Asia-Pacific
        • 5.3.4.3. Europe
          • 5.3.4.3.1. Germany
          • 5.3.4.3.2. France
          • 5.3.4.3.3. Italy
          • 5.3.4.3.4. United Kingdom
          • 5.3.4.3.5. Netherlands
          • 5.3.4.3.6. Rest of Europe
        • 5.3.4.4. MEA
          • 5.3.4.4.1. Middle East
          • 5.3.4.4.2. Africa
        • 5.3.4.5. North America
          • 5.3.4.5.1. United States
          • 5.3.4.5.2. Canada
          • 5.3.4.5.3. Mexico
    • 5.4. Global Bio-Implants (Price)
      • 5.4.1. Global Bio-Implants by: Type (Price)
  • 6. Bio-Implants: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2023)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. AAP Implantate (Germany)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Abbott Laboratories (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Bausch And Lomb Incorporated (Canada)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Biomet (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Biotronik Se & Co.Kg (Germany)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Boston Scientific Corporation (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Cook Group (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. C.R. Bard (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Edwards Lifesciences Corporation (Unites States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Endo Health Solutions (Dublin)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
      • 6.4.11. Johnson & Johnson (Unites States)
        • 6.4.11.1. Business Overview
        • 6.4.11.2. Products/Services Offerings
        • 6.4.11.3. Financial Analysis
        • 6.4.11.4. SWOT Analysis
  • 7. Global Bio-Implants Sale, by Type, End Users, Material and Region (value, volume and price ) (2025-2030)
    • 7.1. Introduction
    • 7.2. Global Bio-Implants (Value)
      • 7.2.1. Global Bio-Implants by: Type (Value)
        • 7.2.1.1. Cardiovascular Implants
        • 7.2.1.2. Spinal implants
        • 7.2.1.3. Orthopedic Implants
        • 7.2.1.4. Dental Implants
        • 7.2.1.5. Ophthalmic Implants
        • 7.2.1.6. Others
      • 7.2.2. Global Bio-Implants by: End Users (Value)
        • 7.2.2.1. Hospitals
        • 7.2.2.2. Clinics
        • 7.2.2.3. Ambulatory Surgical Centers
        • 7.2.2.4. Others
      • 7.2.3. Global Bio-Implants by: Material (Value)
        • 7.2.3.1. Ceramics
        • 7.2.3.2. Polymers
        • 7.2.3.3. Alloys
        • 7.2.3.4. Biomaterials Metals
        • 7.2.3.5. Others
      • 7.2.4. Global Bio-Implants Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
    • 7.3. Global Bio-Implants (Volume)
      • 7.3.1. Global Bio-Implants by: Type (Volume)
        • 7.3.1.1. Cardiovascular Implants
        • 7.3.1.2. Spinal implants
        • 7.3.1.3. Orthopedic Implants
        • 7.3.1.4. Dental Implants
        • 7.3.1.5. Ophthalmic Implants
        • 7.3.1.6. Others
      • 7.3.2. Global Bio-Implants by: End Users (Volume)
        • 7.3.2.1. Hospitals
        • 7.3.2.2. Clinics
        • 7.3.2.3. Ambulatory Surgical Centers
        • 7.3.2.4. Others
      • 7.3.3. Global Bio-Implants by: Material (Volume)
        • 7.3.3.1. Ceramics
        • 7.3.3.2. Polymers
        • 7.3.3.3. Alloys
        • 7.3.3.4. Biomaterials Metals
        • 7.3.3.5. Others
      • 7.3.4. Global Bio-Implants Region
        • 7.3.4.1. South America
          • 7.3.4.1.1. Brazil
          • 7.3.4.1.2. Argentina
          • 7.3.4.1.3. Rest of South America
        • 7.3.4.2. Asia Pacific
          • 7.3.4.2.1. China
          • 7.3.4.2.2. Japan
          • 7.3.4.2.3. India
          • 7.3.4.2.4. South Korea
          • 7.3.4.2.5. Taiwan
          • 7.3.4.2.6. Australia
          • 7.3.4.2.7. Rest of Asia-Pacific
        • 7.3.4.3. Europe
          • 7.3.4.3.1. Germany
          • 7.3.4.3.2. France
          • 7.3.4.3.3. Italy
          • 7.3.4.3.4. United Kingdom
          • 7.3.4.3.5. Netherlands
          • 7.3.4.3.6. Rest of Europe
        • 7.3.4.4. MEA
          • 7.3.4.4.1. Middle East
          • 7.3.4.4.2. Africa
        • 7.3.4.5. North America
          • 7.3.4.5.1. United States
          • 7.3.4.5.2. Canada
          • 7.3.4.5.3. Mexico
    • 7.4. Global Bio-Implants (Price)
      • 7.4.1. Global Bio-Implants by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Bio-Implants: by Type(USD Million)
  • Table 2. Bio-Implants Cardiovascular Implants , by Region USD Million (2018-2023)
  • Table 3. Bio-Implants Spinal implants , by Region USD Million (2018-2023)
  • Table 4. Bio-Implants Orthopedic Implants , by Region USD Million (2018-2023)
  • Table 5. Bio-Implants Dental Implants , by Region USD Million (2018-2023)
  • Table 6. Bio-Implants Ophthalmic Implants , by Region USD Million (2018-2023)
  • Table 7. Bio-Implants Others , by Region USD Million (2018-2023)
  • Table 8. Bio-Implants: by End Users(USD Million)
  • Table 9. Bio-Implants Hospitals , by Region USD Million (2018-2023)
  • Table 10. Bio-Implants Clinics , by Region USD Million (2018-2023)
  • Table 11. Bio-Implants Ambulatory Surgical Centers , by Region USD Million (2018-2023)
  • Table 12. Bio-Implants Others , by Region USD Million (2018-2023)
  • Table 13. Bio-Implants: by Material(USD Million)
  • Table 14. Bio-Implants Ceramics , by Region USD Million (2018-2023)
  • Table 15. Bio-Implants Polymers , by Region USD Million (2018-2023)
  • Table 16. Bio-Implants Alloys , by Region USD Million (2018-2023)
  • Table 17. Bio-Implants Biomaterials Metals , by Region USD Million (2018-2023)
  • Table 18. Bio-Implants Others , by Region USD Million (2018-2023)
  • Table 19. South America Bio-Implants, by Country USD Million (2018-2023)
  • Table 20. South America Bio-Implants, by Type USD Million (2018-2023)
  • Table 21. South America Bio-Implants, by End Users USD Million (2018-2023)
  • Table 22. South America Bio-Implants, by Material USD Million (2018-2023)
  • Table 23. Brazil Bio-Implants, by Type USD Million (2018-2023)
  • Table 24. Brazil Bio-Implants, by End Users USD Million (2018-2023)
  • Table 25. Brazil Bio-Implants, by Material USD Million (2018-2023)
  • Table 26. Argentina Bio-Implants, by Type USD Million (2018-2023)
  • Table 27. Argentina Bio-Implants, by End Users USD Million (2018-2023)
  • Table 28. Argentina Bio-Implants, by Material USD Million (2018-2023)
  • Table 29. Rest of South America Bio-Implants, by Type USD Million (2018-2023)
  • Table 30. Rest of South America Bio-Implants, by End Users USD Million (2018-2023)
  • Table 31. Rest of South America Bio-Implants, by Material USD Million (2018-2023)
  • Table 32. Asia Pacific Bio-Implants, by Country USD Million (2018-2023)
  • Table 33. Asia Pacific Bio-Implants, by Type USD Million (2018-2023)
  • Table 34. Asia Pacific Bio-Implants, by End Users USD Million (2018-2023)
  • Table 35. Asia Pacific Bio-Implants, by Material USD Million (2018-2023)
  • Table 36. China Bio-Implants, by Type USD Million (2018-2023)
  • Table 37. China Bio-Implants, by End Users USD Million (2018-2023)
  • Table 38. China Bio-Implants, by Material USD Million (2018-2023)
  • Table 39. Japan Bio-Implants, by Type USD Million (2018-2023)
  • Table 40. Japan Bio-Implants, by End Users USD Million (2018-2023)
  • Table 41. Japan Bio-Implants, by Material USD Million (2018-2023)
  • Table 42. India Bio-Implants, by Type USD Million (2018-2023)
  • Table 43. India Bio-Implants, by End Users USD Million (2018-2023)
  • Table 44. India Bio-Implants, by Material USD Million (2018-2023)
  • Table 45. South Korea Bio-Implants, by Type USD Million (2018-2023)
  • Table 46. South Korea Bio-Implants, by End Users USD Million (2018-2023)
  • Table 47. South Korea Bio-Implants, by Material USD Million (2018-2023)
  • Table 48. Taiwan Bio-Implants, by Type USD Million (2018-2023)
  • Table 49. Taiwan Bio-Implants, by End Users USD Million (2018-2023)
  • Table 50. Taiwan Bio-Implants, by Material USD Million (2018-2023)
  • Table 51. Australia Bio-Implants, by Type USD Million (2018-2023)
  • Table 52. Australia Bio-Implants, by End Users USD Million (2018-2023)
  • Table 53. Australia Bio-Implants, by Material USD Million (2018-2023)
  • Table 54. Rest of Asia-Pacific Bio-Implants, by Type USD Million (2018-2023)
  • Table 55. Rest of Asia-Pacific Bio-Implants, by End Users USD Million (2018-2023)
  • Table 56. Rest of Asia-Pacific Bio-Implants, by Material USD Million (2018-2023)
  • Table 57. Europe Bio-Implants, by Country USD Million (2018-2023)
  • Table 58. Europe Bio-Implants, by Type USD Million (2018-2023)
  • Table 59. Europe Bio-Implants, by End Users USD Million (2018-2023)
  • Table 60. Europe Bio-Implants, by Material USD Million (2018-2023)
  • Table 61. Germany Bio-Implants, by Type USD Million (2018-2023)
  • Table 62. Germany Bio-Implants, by End Users USD Million (2018-2023)
  • Table 63. Germany Bio-Implants, by Material USD Million (2018-2023)
  • Table 64. France Bio-Implants, by Type USD Million (2018-2023)
  • Table 65. France Bio-Implants, by End Users USD Million (2018-2023)
  • Table 66. France Bio-Implants, by Material USD Million (2018-2023)
  • Table 67. Italy Bio-Implants, by Type USD Million (2018-2023)
  • Table 68. Italy Bio-Implants, by End Users USD Million (2018-2023)
  • Table 69. Italy Bio-Implants, by Material USD Million (2018-2023)
  • Table 70. United Kingdom Bio-Implants, by Type USD Million (2018-2023)
  • Table 71. United Kingdom Bio-Implants, by End Users USD Million (2018-2023)
  • Table 72. United Kingdom Bio-Implants, by Material USD Million (2018-2023)
  • Table 73. Netherlands Bio-Implants, by Type USD Million (2018-2023)
  • Table 74. Netherlands Bio-Implants, by End Users USD Million (2018-2023)
  • Table 75. Netherlands Bio-Implants, by Material USD Million (2018-2023)
  • Table 76. Rest of Europe Bio-Implants, by Type USD Million (2018-2023)
  • Table 77. Rest of Europe Bio-Implants, by End Users USD Million (2018-2023)
  • Table 78. Rest of Europe Bio-Implants, by Material USD Million (2018-2023)
  • Table 79. MEA Bio-Implants, by Country USD Million (2018-2023)
  • Table 80. MEA Bio-Implants, by Type USD Million (2018-2023)
  • Table 81. MEA Bio-Implants, by End Users USD Million (2018-2023)
  • Table 82. MEA Bio-Implants, by Material USD Million (2018-2023)
  • Table 83. Middle East Bio-Implants, by Type USD Million (2018-2023)
  • Table 84. Middle East Bio-Implants, by End Users USD Million (2018-2023)
  • Table 85. Middle East Bio-Implants, by Material USD Million (2018-2023)
  • Table 86. Africa Bio-Implants, by Type USD Million (2018-2023)
  • Table 87. Africa Bio-Implants, by End Users USD Million (2018-2023)
  • Table 88. Africa Bio-Implants, by Material USD Million (2018-2023)
  • Table 89. North America Bio-Implants, by Country USD Million (2018-2023)
  • Table 90. North America Bio-Implants, by Type USD Million (2018-2023)
  • Table 91. North America Bio-Implants, by End Users USD Million (2018-2023)
  • Table 92. North America Bio-Implants, by Material USD Million (2018-2023)
  • Table 93. United States Bio-Implants, by Type USD Million (2018-2023)
  • Table 94. United States Bio-Implants, by End Users USD Million (2018-2023)
  • Table 95. United States Bio-Implants, by Material USD Million (2018-2023)
  • Table 96. Canada Bio-Implants, by Type USD Million (2018-2023)
  • Table 97. Canada Bio-Implants, by End Users USD Million (2018-2023)
  • Table 98. Canada Bio-Implants, by Material USD Million (2018-2023)
  • Table 99. Mexico Bio-Implants, by Type USD Million (2018-2023)
  • Table 100. Mexico Bio-Implants, by End Users USD Million (2018-2023)
  • Table 101. Mexico Bio-Implants, by Material USD Million (2018-2023)
  • Table 102. Bio-Implants Sales: by Type(K Units)
  • Table 103. Bio-Implants Sales Cardiovascular Implants , by Region K Units (2018-2023)
  • Table 104. Bio-Implants Sales Spinal implants , by Region K Units (2018-2023)
  • Table 105. Bio-Implants Sales Orthopedic Implants , by Region K Units (2018-2023)
  • Table 106. Bio-Implants Sales Dental Implants , by Region K Units (2018-2023)
  • Table 107. Bio-Implants Sales Ophthalmic Implants , by Region K Units (2018-2023)
  • Table 108. Bio-Implants Sales Others , by Region K Units (2018-2023)
  • Table 109. Bio-Implants Sales: by End Users(K Units)
  • Table 110. Bio-Implants Sales Hospitals , by Region K Units (2018-2023)
  • Table 111. Bio-Implants Sales Clinics , by Region K Units (2018-2023)
  • Table 112. Bio-Implants Sales Ambulatory Surgical Centers , by Region K Units (2018-2023)
  • Table 113. Bio-Implants Sales Others , by Region K Units (2018-2023)
  • Table 114. Bio-Implants Sales: by Material(K Units)
  • Table 115. Bio-Implants Sales Ceramics , by Region K Units (2018-2023)
  • Table 116. Bio-Implants Sales Polymers , by Region K Units (2018-2023)
  • Table 117. Bio-Implants Sales Alloys , by Region K Units (2018-2023)
  • Table 118. Bio-Implants Sales Biomaterials Metals , by Region K Units (2018-2023)
  • Table 119. Bio-Implants Sales Others , by Region K Units (2018-2023)
  • Table 120. South America Bio-Implants Sales, by Country K Units (2018-2023)
  • Table 121. South America Bio-Implants Sales, by Type K Units (2018-2023)
  • Table 122. South America Bio-Implants Sales, by End Users K Units (2018-2023)
  • Table 123. South America Bio-Implants Sales, by Material K Units (2018-2023)
  • Table 124. Brazil Bio-Implants Sales, by Type K Units (2018-2023)
  • Table 125. Brazil Bio-Implants Sales, by End Users K Units (2018-2023)
  • Table 126. Brazil Bio-Implants Sales, by Material K Units (2018-2023)
  • Table 127. Argentina Bio-Implants Sales, by Type K Units (2018-2023)
  • Table 128. Argentina Bio-Implants Sales, by End Users K Units (2018-2023)
  • Table 129. Argentina Bio-Implants Sales, by Material K Units (2018-2023)
  • Table 130. Rest of South America Bio-Implants Sales, by Type K Units (2018-2023)
  • Table 131. Rest of South America Bio-Implants Sales, by End Users K Units (2018-2023)
  • Table 132. Rest of South America Bio-Implants Sales, by Material K Units (2018-2023)
  • Table 133. Asia Pacific Bio-Implants Sales, by Country K Units (2018-2023)
  • Table 134. Asia Pacific Bio-Implants Sales, by Type K Units (2018-2023)
  • Table 135. Asia Pacific Bio-Implants Sales, by End Users K Units (2018-2023)
  • Table 136. Asia Pacific Bio-Implants Sales, by Material K Units (2018-2023)
  • Table 137. China Bio-Implants Sales, by Type K Units (2018-2023)
  • Table 138. China Bio-Implants Sales, by End Users K Units (2018-2023)
  • Table 139. China Bio-Implants Sales, by Material K Units (2018-2023)
  • Table 140. Japan Bio-Implants Sales, by Type K Units (2018-2023)
  • Table 141. Japan Bio-Implants Sales, by End Users K Units (2018-2023)
  • Table 142. Japan Bio-Implants Sales, by Material K Units (2018-2023)
  • Table 143. India Bio-Implants Sales, by Type K Units (2018-2023)
  • Table 144. India Bio-Implants Sales, by End Users K Units (2018-2023)
  • Table 145. India Bio-Implants Sales, by Material K Units (2018-2023)
  • Table 146. South Korea Bio-Implants Sales, by Type K Units (2018-2023)
  • Table 147. South Korea Bio-Implants Sales, by End Users K Units (2018-2023)
  • Table 148. South Korea Bio-Implants Sales, by Material K Units (2018-2023)
  • Table 149. Taiwan Bio-Implants Sales, by Type K Units (2018-2023)
  • Table 150. Taiwan Bio-Implants Sales, by End Users K Units (2018-2023)
  • Table 151. Taiwan Bio-Implants Sales, by Material K Units (2018-2023)
  • Table 152. Australia Bio-Implants Sales, by Type K Units (2018-2023)
  • Table 153. Australia Bio-Implants Sales, by End Users K Units (2018-2023)
  • Table 154. Australia Bio-Implants Sales, by Material K Units (2018-2023)
  • Table 155. Rest of Asia-Pacific Bio-Implants Sales, by Type K Units (2018-2023)
  • Table 156. Rest of Asia-Pacific Bio-Implants Sales, by End Users K Units (2018-2023)
  • Table 157. Rest of Asia-Pacific Bio-Implants Sales, by Material K Units (2018-2023)
  • Table 158. Europe Bio-Implants Sales, by Country K Units (2018-2023)
  • Table 159. Europe Bio-Implants Sales, by Type K Units (2018-2023)
  • Table 160. Europe Bio-Implants Sales, by End Users K Units (2018-2023)
  • Table 161. Europe Bio-Implants Sales, by Material K Units (2018-2023)
  • Table 162. Germany Bio-Implants Sales, by Type K Units (2018-2023)
  • Table 163. Germany Bio-Implants Sales, by End Users K Units (2018-2023)
  • Table 164. Germany Bio-Implants Sales, by Material K Units (2018-2023)
  • Table 165. France Bio-Implants Sales, by Type K Units (2018-2023)
  • Table 166. France Bio-Implants Sales, by End Users K Units (2018-2023)
  • Table 167. France Bio-Implants Sales, by Material K Units (2018-2023)
  • Table 168. Italy Bio-Implants Sales, by Type K Units (2018-2023)
  • Table 169. Italy Bio-Implants Sales, by End Users K Units (2018-2023)
  • Table 170. Italy Bio-Implants Sales, by Material K Units (2018-2023)
  • Table 171. United Kingdom Bio-Implants Sales, by Type K Units (2018-2023)
  • Table 172. United Kingdom Bio-Implants Sales, by End Users K Units (2018-2023)
  • Table 173. United Kingdom Bio-Implants Sales, by Material K Units (2018-2023)
  • Table 174. Netherlands Bio-Implants Sales, by Type K Units (2018-2023)
  • Table 175. Netherlands Bio-Implants Sales, by End Users K Units (2018-2023)
  • Table 176. Netherlands Bio-Implants Sales, by Material K Units (2018-2023)
  • Table 177. Rest of Europe Bio-Implants Sales, by Type K Units (2018-2023)
  • Table 178. Rest of Europe Bio-Implants Sales, by End Users K Units (2018-2023)
  • Table 179. Rest of Europe Bio-Implants Sales, by Material K Units (2018-2023)
  • Table 180. MEA Bio-Implants Sales, by Country K Units (2018-2023)
  • Table 181. MEA Bio-Implants Sales, by Type K Units (2018-2023)
  • Table 182. MEA Bio-Implants Sales, by End Users K Units (2018-2023)
  • Table 183. MEA Bio-Implants Sales, by Material K Units (2018-2023)
  • Table 184. Middle East Bio-Implants Sales, by Type K Units (2018-2023)
  • Table 185. Middle East Bio-Implants Sales, by End Users K Units (2018-2023)
  • Table 186. Middle East Bio-Implants Sales, by Material K Units (2018-2023)
  • Table 187. Africa Bio-Implants Sales, by Type K Units (2018-2023)
  • Table 188. Africa Bio-Implants Sales, by End Users K Units (2018-2023)
  • Table 189. Africa Bio-Implants Sales, by Material K Units (2018-2023)
  • Table 190. North America Bio-Implants Sales, by Country K Units (2018-2023)
  • Table 191. North America Bio-Implants Sales, by Type K Units (2018-2023)
  • Table 192. North America Bio-Implants Sales, by End Users K Units (2018-2023)
  • Table 193. North America Bio-Implants Sales, by Material K Units (2018-2023)
  • Table 194. United States Bio-Implants Sales, by Type K Units (2018-2023)
  • Table 195. United States Bio-Implants Sales, by End Users K Units (2018-2023)
  • Table 196. United States Bio-Implants Sales, by Material K Units (2018-2023)
  • Table 197. Canada Bio-Implants Sales, by Type K Units (2018-2023)
  • Table 198. Canada Bio-Implants Sales, by End Users K Units (2018-2023)
  • Table 199. Canada Bio-Implants Sales, by Material K Units (2018-2023)
  • Table 200. Mexico Bio-Implants Sales, by Type K Units (2018-2023)
  • Table 201. Mexico Bio-Implants Sales, by End Users K Units (2018-2023)
  • Table 202. Mexico Bio-Implants Sales, by Material K Units (2018-2023)
  • Table 203. Bio-Implants: by Type(USD/Units)
  • Table 204. Company Basic Information, Sales Area and Its Competitors
  • Table 205. Company Basic Information, Sales Area and Its Competitors
  • Table 206. Company Basic Information, Sales Area and Its Competitors
  • Table 207. Company Basic Information, Sales Area and Its Competitors
  • Table 208. Company Basic Information, Sales Area and Its Competitors
  • Table 209. Company Basic Information, Sales Area and Its Competitors
  • Table 210. Company Basic Information, Sales Area and Its Competitors
  • Table 211. Company Basic Information, Sales Area and Its Competitors
  • Table 212. Company Basic Information, Sales Area and Its Competitors
  • Table 213. Company Basic Information, Sales Area and Its Competitors
  • Table 214. Company Basic Information, Sales Area and Its Competitors
  • Table 215. Bio-Implants: by Type(USD Million)
  • Table 216. Bio-Implants Cardiovascular Implants , by Region USD Million (2025-2030)
  • Table 217. Bio-Implants Spinal implants , by Region USD Million (2025-2030)
  • Table 218. Bio-Implants Orthopedic Implants , by Region USD Million (2025-2030)
  • Table 219. Bio-Implants Dental Implants , by Region USD Million (2025-2030)
  • Table 220. Bio-Implants Ophthalmic Implants , by Region USD Million (2025-2030)
  • Table 221. Bio-Implants Others , by Region USD Million (2025-2030)
  • Table 222. Bio-Implants: by End Users(USD Million)
  • Table 223. Bio-Implants Hospitals , by Region USD Million (2025-2030)
  • Table 224. Bio-Implants Clinics , by Region USD Million (2025-2030)
  • Table 225. Bio-Implants Ambulatory Surgical Centers , by Region USD Million (2025-2030)
  • Table 226. Bio-Implants Others , by Region USD Million (2025-2030)
  • Table 227. Bio-Implants: by Material(USD Million)
  • Table 228. Bio-Implants Ceramics , by Region USD Million (2025-2030)
  • Table 229. Bio-Implants Polymers , by Region USD Million (2025-2030)
  • Table 230. Bio-Implants Alloys , by Region USD Million (2025-2030)
  • Table 231. Bio-Implants Biomaterials Metals , by Region USD Million (2025-2030)
  • Table 232. Bio-Implants Others , by Region USD Million (2025-2030)
  • Table 233. South America Bio-Implants, by Country USD Million (2025-2030)
  • Table 234. South America Bio-Implants, by Type USD Million (2025-2030)
  • Table 235. South America Bio-Implants, by End Users USD Million (2025-2030)
  • Table 236. South America Bio-Implants, by Material USD Million (2025-2030)
  • Table 237. Brazil Bio-Implants, by Type USD Million (2025-2030)
  • Table 238. Brazil Bio-Implants, by End Users USD Million (2025-2030)
  • Table 239. Brazil Bio-Implants, by Material USD Million (2025-2030)
  • Table 240. Argentina Bio-Implants, by Type USD Million (2025-2030)
  • Table 241. Argentina Bio-Implants, by End Users USD Million (2025-2030)
  • Table 242. Argentina Bio-Implants, by Material USD Million (2025-2030)
  • Table 243. Rest of South America Bio-Implants, by Type USD Million (2025-2030)
  • Table 244. Rest of South America Bio-Implants, by End Users USD Million (2025-2030)
  • Table 245. Rest of South America Bio-Implants, by Material USD Million (2025-2030)
  • Table 246. Asia Pacific Bio-Implants, by Country USD Million (2025-2030)
  • Table 247. Asia Pacific Bio-Implants, by Type USD Million (2025-2030)
  • Table 248. Asia Pacific Bio-Implants, by End Users USD Million (2025-2030)
  • Table 249. Asia Pacific Bio-Implants, by Material USD Million (2025-2030)
  • Table 250. China Bio-Implants, by Type USD Million (2025-2030)
  • Table 251. China Bio-Implants, by End Users USD Million (2025-2030)
  • Table 252. China Bio-Implants, by Material USD Million (2025-2030)
  • Table 253. Japan Bio-Implants, by Type USD Million (2025-2030)
  • Table 254. Japan Bio-Implants, by End Users USD Million (2025-2030)
  • Table 255. Japan Bio-Implants, by Material USD Million (2025-2030)
  • Table 256. India Bio-Implants, by Type USD Million (2025-2030)
  • Table 257. India Bio-Implants, by End Users USD Million (2025-2030)
  • Table 258. India Bio-Implants, by Material USD Million (2025-2030)
  • Table 259. South Korea Bio-Implants, by Type USD Million (2025-2030)
  • Table 260. South Korea Bio-Implants, by End Users USD Million (2025-2030)
  • Table 261. South Korea Bio-Implants, by Material USD Million (2025-2030)
  • Table 262. Taiwan Bio-Implants, by Type USD Million (2025-2030)
  • Table 263. Taiwan Bio-Implants, by End Users USD Million (2025-2030)
  • Table 264. Taiwan Bio-Implants, by Material USD Million (2025-2030)
  • Table 265. Australia Bio-Implants, by Type USD Million (2025-2030)
  • Table 266. Australia Bio-Implants, by End Users USD Million (2025-2030)
  • Table 267. Australia Bio-Implants, by Material USD Million (2025-2030)
  • Table 268. Rest of Asia-Pacific Bio-Implants, by Type USD Million (2025-2030)
  • Table 269. Rest of Asia-Pacific Bio-Implants, by End Users USD Million (2025-2030)
  • Table 270. Rest of Asia-Pacific Bio-Implants, by Material USD Million (2025-2030)
  • Table 271. Europe Bio-Implants, by Country USD Million (2025-2030)
  • Table 272. Europe Bio-Implants, by Type USD Million (2025-2030)
  • Table 273. Europe Bio-Implants, by End Users USD Million (2025-2030)
  • Table 274. Europe Bio-Implants, by Material USD Million (2025-2030)
  • Table 275. Germany Bio-Implants, by Type USD Million (2025-2030)
  • Table 276. Germany Bio-Implants, by End Users USD Million (2025-2030)
  • Table 277. Germany Bio-Implants, by Material USD Million (2025-2030)
  • Table 278. France Bio-Implants, by Type USD Million (2025-2030)
  • Table 279. France Bio-Implants, by End Users USD Million (2025-2030)
  • Table 280. France Bio-Implants, by Material USD Million (2025-2030)
  • Table 281. Italy Bio-Implants, by Type USD Million (2025-2030)
  • Table 282. Italy Bio-Implants, by End Users USD Million (2025-2030)
  • Table 283. Italy Bio-Implants, by Material USD Million (2025-2030)
  • Table 284. United Kingdom Bio-Implants, by Type USD Million (2025-2030)
  • Table 285. United Kingdom Bio-Implants, by End Users USD Million (2025-2030)
  • Table 286. United Kingdom Bio-Implants, by Material USD Million (2025-2030)
  • Table 287. Netherlands Bio-Implants, by Type USD Million (2025-2030)
  • Table 288. Netherlands Bio-Implants, by End Users USD Million (2025-2030)
  • Table 289. Netherlands Bio-Implants, by Material USD Million (2025-2030)
  • Table 290. Rest of Europe Bio-Implants, by Type USD Million (2025-2030)
  • Table 291. Rest of Europe Bio-Implants, by End Users USD Million (2025-2030)
  • Table 292. Rest of Europe Bio-Implants, by Material USD Million (2025-2030)
  • Table 293. MEA Bio-Implants, by Country USD Million (2025-2030)
  • Table 294. MEA Bio-Implants, by Type USD Million (2025-2030)
  • Table 295. MEA Bio-Implants, by End Users USD Million (2025-2030)
  • Table 296. MEA Bio-Implants, by Material USD Million (2025-2030)
  • Table 297. Middle East Bio-Implants, by Type USD Million (2025-2030)
  • Table 298. Middle East Bio-Implants, by End Users USD Million (2025-2030)
  • Table 299. Middle East Bio-Implants, by Material USD Million (2025-2030)
  • Table 300. Africa Bio-Implants, by Type USD Million (2025-2030)
  • Table 301. Africa Bio-Implants, by End Users USD Million (2025-2030)
  • Table 302. Africa Bio-Implants, by Material USD Million (2025-2030)
  • Table 303. North America Bio-Implants, by Country USD Million (2025-2030)
  • Table 304. North America Bio-Implants, by Type USD Million (2025-2030)
  • Table 305. North America Bio-Implants, by End Users USD Million (2025-2030)
  • Table 306. North America Bio-Implants, by Material USD Million (2025-2030)
  • Table 307. United States Bio-Implants, by Type USD Million (2025-2030)
  • Table 308. United States Bio-Implants, by End Users USD Million (2025-2030)
  • Table 309. United States Bio-Implants, by Material USD Million (2025-2030)
  • Table 310. Canada Bio-Implants, by Type USD Million (2025-2030)
  • Table 311. Canada Bio-Implants, by End Users USD Million (2025-2030)
  • Table 312. Canada Bio-Implants, by Material USD Million (2025-2030)
  • Table 313. Mexico Bio-Implants, by Type USD Million (2025-2030)
  • Table 314. Mexico Bio-Implants, by End Users USD Million (2025-2030)
  • Table 315. Mexico Bio-Implants, by Material USD Million (2025-2030)
  • Table 316. Bio-Implants Sales: by Type(K Units)
  • Table 317. Bio-Implants Sales Cardiovascular Implants , by Region K Units (2025-2030)
  • Table 318. Bio-Implants Sales Spinal implants , by Region K Units (2025-2030)
  • Table 319. Bio-Implants Sales Orthopedic Implants , by Region K Units (2025-2030)
  • Table 320. Bio-Implants Sales Dental Implants , by Region K Units (2025-2030)
  • Table 321. Bio-Implants Sales Ophthalmic Implants , by Region K Units (2025-2030)
  • Table 322. Bio-Implants Sales Others , by Region K Units (2025-2030)
  • Table 323. Bio-Implants Sales: by End Users(K Units)
  • Table 324. Bio-Implants Sales Hospitals , by Region K Units (2025-2030)
  • Table 325. Bio-Implants Sales Clinics , by Region K Units (2025-2030)
  • Table 326. Bio-Implants Sales Ambulatory Surgical Centers , by Region K Units (2025-2030)
  • Table 327. Bio-Implants Sales Others , by Region K Units (2025-2030)
  • Table 328. Bio-Implants Sales: by Material(K Units)
  • Table 329. Bio-Implants Sales Ceramics , by Region K Units (2025-2030)
  • Table 330. Bio-Implants Sales Polymers , by Region K Units (2025-2030)
  • Table 331. Bio-Implants Sales Alloys , by Region K Units (2025-2030)
  • Table 332. Bio-Implants Sales Biomaterials Metals , by Region K Units (2025-2030)
  • Table 333. Bio-Implants Sales Others , by Region K Units (2025-2030)
  • Table 334. South America Bio-Implants Sales, by Country K Units (2025-2030)
  • Table 335. South America Bio-Implants Sales, by Type K Units (2025-2030)
  • Table 336. South America Bio-Implants Sales, by End Users K Units (2025-2030)
  • Table 337. South America Bio-Implants Sales, by Material K Units (2025-2030)
  • Table 338. Brazil Bio-Implants Sales, by Type K Units (2025-2030)
  • Table 339. Brazil Bio-Implants Sales, by End Users K Units (2025-2030)
  • Table 340. Brazil Bio-Implants Sales, by Material K Units (2025-2030)
  • Table 341. Argentina Bio-Implants Sales, by Type K Units (2025-2030)
  • Table 342. Argentina Bio-Implants Sales, by End Users K Units (2025-2030)
  • Table 343. Argentina Bio-Implants Sales, by Material K Units (2025-2030)
  • Table 344. Rest of South America Bio-Implants Sales, by Type K Units (2025-2030)
  • Table 345. Rest of South America Bio-Implants Sales, by End Users K Units (2025-2030)
  • Table 346. Rest of South America Bio-Implants Sales, by Material K Units (2025-2030)
  • Table 347. Asia Pacific Bio-Implants Sales, by Country K Units (2025-2030)
  • Table 348. Asia Pacific Bio-Implants Sales, by Type K Units (2025-2030)
  • Table 349. Asia Pacific Bio-Implants Sales, by End Users K Units (2025-2030)
  • Table 350. Asia Pacific Bio-Implants Sales, by Material K Units (2025-2030)
  • Table 351. China Bio-Implants Sales, by Type K Units (2025-2030)
  • Table 352. China Bio-Implants Sales, by End Users K Units (2025-2030)
  • Table 353. China Bio-Implants Sales, by Material K Units (2025-2030)
  • Table 354. Japan Bio-Implants Sales, by Type K Units (2025-2030)
  • Table 355. Japan Bio-Implants Sales, by End Users K Units (2025-2030)
  • Table 356. Japan Bio-Implants Sales, by Material K Units (2025-2030)
  • Table 357. India Bio-Implants Sales, by Type K Units (2025-2030)
  • Table 358. India Bio-Implants Sales, by End Users K Units (2025-2030)
  • Table 359. India Bio-Implants Sales, by Material K Units (2025-2030)
  • Table 360. South Korea Bio-Implants Sales, by Type K Units (2025-2030)
  • Table 361. South Korea Bio-Implants Sales, by End Users K Units (2025-2030)
  • Table 362. South Korea Bio-Implants Sales, by Material K Units (2025-2030)
  • Table 363. Taiwan Bio-Implants Sales, by Type K Units (2025-2030)
  • Table 364. Taiwan Bio-Implants Sales, by End Users K Units (2025-2030)
  • Table 365. Taiwan Bio-Implants Sales, by Material K Units (2025-2030)
  • Table 366. Australia Bio-Implants Sales, by Type K Units (2025-2030)
  • Table 367. Australia Bio-Implants Sales, by End Users K Units (2025-2030)
  • Table 368. Australia Bio-Implants Sales, by Material K Units (2025-2030)
  • Table 369. Rest of Asia-Pacific Bio-Implants Sales, by Type K Units (2025-2030)
  • Table 370. Rest of Asia-Pacific Bio-Implants Sales, by End Users K Units (2025-2030)
  • Table 371. Rest of Asia-Pacific Bio-Implants Sales, by Material K Units (2025-2030)
  • Table 372. Europe Bio-Implants Sales, by Country K Units (2025-2030)
  • Table 373. Europe Bio-Implants Sales, by Type K Units (2025-2030)
  • Table 374. Europe Bio-Implants Sales, by End Users K Units (2025-2030)
  • Table 375. Europe Bio-Implants Sales, by Material K Units (2025-2030)
  • Table 376. Germany Bio-Implants Sales, by Type K Units (2025-2030)
  • Table 377. Germany Bio-Implants Sales, by End Users K Units (2025-2030)
  • Table 378. Germany Bio-Implants Sales, by Material K Units (2025-2030)
  • Table 379. France Bio-Implants Sales, by Type K Units (2025-2030)
  • Table 380. France Bio-Implants Sales, by End Users K Units (2025-2030)
  • Table 381. France Bio-Implants Sales, by Material K Units (2025-2030)
  • Table 382. Italy Bio-Implants Sales, by Type K Units (2025-2030)
  • Table 383. Italy Bio-Implants Sales, by End Users K Units (2025-2030)
  • Table 384. Italy Bio-Implants Sales, by Material K Units (2025-2030)
  • Table 385. United Kingdom Bio-Implants Sales, by Type K Units (2025-2030)
  • Table 386. United Kingdom Bio-Implants Sales, by End Users K Units (2025-2030)
  • Table 387. United Kingdom Bio-Implants Sales, by Material K Units (2025-2030)
  • Table 388. Netherlands Bio-Implants Sales, by Type K Units (2025-2030)
  • Table 389. Netherlands Bio-Implants Sales, by End Users K Units (2025-2030)
  • Table 390. Netherlands Bio-Implants Sales, by Material K Units (2025-2030)
  • Table 391. Rest of Europe Bio-Implants Sales, by Type K Units (2025-2030)
  • Table 392. Rest of Europe Bio-Implants Sales, by End Users K Units (2025-2030)
  • Table 393. Rest of Europe Bio-Implants Sales, by Material K Units (2025-2030)
  • Table 394. MEA Bio-Implants Sales, by Country K Units (2025-2030)
  • Table 395. MEA Bio-Implants Sales, by Type K Units (2025-2030)
  • Table 396. MEA Bio-Implants Sales, by End Users K Units (2025-2030)
  • Table 397. MEA Bio-Implants Sales, by Material K Units (2025-2030)
  • Table 398. Middle East Bio-Implants Sales, by Type K Units (2025-2030)
  • Table 399. Middle East Bio-Implants Sales, by End Users K Units (2025-2030)
  • Table 400. Middle East Bio-Implants Sales, by Material K Units (2025-2030)
  • Table 401. Africa Bio-Implants Sales, by Type K Units (2025-2030)
  • Table 402. Africa Bio-Implants Sales, by End Users K Units (2025-2030)
  • Table 403. Africa Bio-Implants Sales, by Material K Units (2025-2030)
  • Table 404. North America Bio-Implants Sales, by Country K Units (2025-2030)
  • Table 405. North America Bio-Implants Sales, by Type K Units (2025-2030)
  • Table 406. North America Bio-Implants Sales, by End Users K Units (2025-2030)
  • Table 407. North America Bio-Implants Sales, by Material K Units (2025-2030)
  • Table 408. United States Bio-Implants Sales, by Type K Units (2025-2030)
  • Table 409. United States Bio-Implants Sales, by End Users K Units (2025-2030)
  • Table 410. United States Bio-Implants Sales, by Material K Units (2025-2030)
  • Table 411. Canada Bio-Implants Sales, by Type K Units (2025-2030)
  • Table 412. Canada Bio-Implants Sales, by End Users K Units (2025-2030)
  • Table 413. Canada Bio-Implants Sales, by Material K Units (2025-2030)
  • Table 414. Mexico Bio-Implants Sales, by Type K Units (2025-2030)
  • Table 415. Mexico Bio-Implants Sales, by End Users K Units (2025-2030)
  • Table 416. Mexico Bio-Implants Sales, by Material K Units (2025-2030)
  • Table 417. Bio-Implants: by Type(USD/Units)
  • Table 418. Research Programs/Design for This Report
  • Table 419. Key Data Information from Secondary Sources
  • Table 420. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Bio-Implants: by Type USD Million (2018-2023)
  • Figure 5. Global Bio-Implants: by End Users USD Million (2018-2023)
  • Figure 6. Global Bio-Implants: by Material USD Million (2018-2023)
  • Figure 7. South America Bio-Implants Share (%), by Country
  • Figure 8. Asia Pacific Bio-Implants Share (%), by Country
  • Figure 9. Europe Bio-Implants Share (%), by Country
  • Figure 10. MEA Bio-Implants Share (%), by Country
  • Figure 11. North America Bio-Implants Share (%), by Country
  • Figure 12. Global Bio-Implants: by Type K Units (2018-2023)
  • Figure 13. Global Bio-Implants: by End Users K Units (2018-2023)
  • Figure 14. Global Bio-Implants: by Material K Units (2018-2023)
  • Figure 15. South America Bio-Implants Share (%), by Country
  • Figure 16. Asia Pacific Bio-Implants Share (%), by Country
  • Figure 17. Europe Bio-Implants Share (%), by Country
  • Figure 18. MEA Bio-Implants Share (%), by Country
  • Figure 19. North America Bio-Implants Share (%), by Country
  • Figure 20. Global Bio-Implants: by Type USD/Units (2018-2023)
  • Figure 21. Global Bio-Implants share by Players 2023 (%)
  • Figure 22. Global Bio-Implants share by Players (Top 3) 2023(%)
  • Figure 23. Global Bio-Implants share by Players (Top 5) 2023(%)
  • Figure 24. BCG Matrix for key Companies
  • Figure 25. AAP Implantate (Germany) Revenue, Net Income and Gross profit
  • Figure 26. AAP Implantate (Germany) Revenue: by Geography 2023
  • Figure 27. Abbott Laboratories (United States) Revenue, Net Income and Gross profit
  • Figure 28. Abbott Laboratories (United States) Revenue: by Geography 2023
  • Figure 29. Bausch And Lomb Incorporated (Canada) Revenue, Net Income and Gross profit
  • Figure 30. Bausch And Lomb Incorporated (Canada) Revenue: by Geography 2023
  • Figure 31. Biomet (United States) Revenue, Net Income and Gross profit
  • Figure 32. Biomet (United States) Revenue: by Geography 2023
  • Figure 33. Biotronik Se & Co.Kg (Germany) Revenue, Net Income and Gross profit
  • Figure 34. Biotronik Se & Co.Kg (Germany) Revenue: by Geography 2023
  • Figure 35. Boston Scientific Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 36. Boston Scientific Corporation (United States) Revenue: by Geography 2023
  • Figure 37. Cook Group (United States) Revenue, Net Income and Gross profit
  • Figure 38. Cook Group (United States) Revenue: by Geography 2023
  • Figure 39. C.R. Bard (United States) Revenue, Net Income and Gross profit
  • Figure 40. C.R. Bard (United States) Revenue: by Geography 2023
  • Figure 41. Edwards Lifesciences Corporation (Unites States) Revenue, Net Income and Gross profit
  • Figure 42. Edwards Lifesciences Corporation (Unites States) Revenue: by Geography 2023
  • Figure 43. Endo Health Solutions (Dublin) Revenue, Net Income and Gross profit
  • Figure 44. Endo Health Solutions (Dublin) Revenue: by Geography 2023
  • Figure 45. Johnson & Johnson (Unites States) Revenue, Net Income and Gross profit
  • Figure 46. Johnson & Johnson (Unites States) Revenue: by Geography 2023
  • Figure 47. Global Bio-Implants: by Type USD Million (2025-2030)
  • Figure 48. Global Bio-Implants: by End Users USD Million (2025-2030)
  • Figure 49. Global Bio-Implants: by Material USD Million (2025-2030)
  • Figure 50. South America Bio-Implants Share (%), by Country
  • Figure 51. Asia Pacific Bio-Implants Share (%), by Country
  • Figure 52. Europe Bio-Implants Share (%), by Country
  • Figure 53. MEA Bio-Implants Share (%), by Country
  • Figure 54. North America Bio-Implants Share (%), by Country
  • Figure 55. Global Bio-Implants: by Type K Units (2025-2030)
  • Figure 56. Global Bio-Implants: by End Users K Units (2025-2030)
  • Figure 57. Global Bio-Implants: by Material K Units (2025-2030)
  • Figure 58. South America Bio-Implants Share (%), by Country
  • Figure 59. Asia Pacific Bio-Implants Share (%), by Country
  • Figure 60. Europe Bio-Implants Share (%), by Country
  • Figure 61. MEA Bio-Implants Share (%), by Country
  • Figure 62. North America Bio-Implants Share (%), by Country
  • Figure 63. Global Bio-Implants: by Type USD/Units (2025-2030)
List of companies from research coverage that are profiled in the study
  • AAP Implantate (Germany)
  • Abbott Laboratories (United States)
  • Bausch And Lomb Incorporated (Canada)
  • Biomet (United States)
  • Biotronik Se & Co.Kg (Germany)
  • Boston Scientific Corporation (United States)
  • Cook Group (United States)
  • C.R. Bard (United States)
  • Edwards Lifesciences Corporation (Unites States)
  • Endo Health Solutions (Dublin)
  • Johnson & Johnson (Unites States)
Additional players considered in the study are as follows:
Mimedx Group (United States) , Orthofix International (United States) , Smith & Nephew (United Kingdom) , Sorin (South korea) , St. Jude Medical (United States) , Integra Lifesciences Holdings Corporation (Unites States)
Select User Access Type

Key Highlights of Report


Feb 2024 239 Pages 96 Tables Base Year: 2023 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The key segments that are playing vital role in Bio-Implants Market are by type [Cardiovascular Implants, Spinal implants, Orthopedic Implants, Dental Implants, Ophthalmic Implants and Others], by end use application [].
The Bio-Implants Market is gaining popularity and expected to see strong valuation by 2030.
  • Increasing Aging Population
  • Rising Preference toward Minimally Invasive Surgeries
  • Increasing Demand of Bioimplants

Know More About Global Bio-Implants Report?